Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 2,500 shares at $38.38 ($96K) on 2019-09-25, disclosed to the SEC on 2019-09-27.
Open-market sale of $96k EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.38 | 2,400 | $92K | 95.9% |
| 2 | $39.15 | 100 | $4K | 4.1% |
| Total | $38.41 avg | 2,500 | $96K | 100% |
| Filing → |
| EIDX | SELL | 2020-10-30 | $456K | — | Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |